Dr. Paul Schaffer is CEO of ARTMS Products and Head of TRIUMF’s Life Sciences division. Paul came to TRIUMF in 2009 from the private sector where he worked at General Electric in upstate New York. He earned his Ph.D. in chemistry from McMaster University in 2003 and earned his B.Sc. with honours in chemistry and biochemistry from the University of British Columbia (UBC) in 1998. He is now also an adjunct professor at Simon Fraser University’s Department of Chemistry and an assistant professor in the Department of Radiology at UBC.
The commendations for Paul are many but he is most recognized for his earnest sincerity, his positive attitude, and his ability to create teams that produce phenomenal results on short time scales. A master of his subject matter, Paul has transformed the TRIUMF nuclear-medicine program by focusing on core competencies, specific outcomes, and connections with industrial and commercial interests.
Nigel S. Lockyer, former director of TRIUMF, commented, “Paul is a leader, an entrepreneur, an inspirational manager, and one of BC’s most promising talents. He is the key researcher looking forward for the laboratory and establishing the major nuclear-medicine research plans and goals for the next two decades.”
Jason S. Lewis, vice chair for research in the Department of Radiology at Memorial Sloan-Kettering Cancer Center, noted, “First and foremost, Paul is an outstanding and accomplished scientist. Not many achieve the level of performance, in terms of both research and leadership, as Paul has attained in his young career. He is a compelling and selfless leader of his team.”